{"id":6882,"date":"2024-04-23T10:35:35","date_gmt":"2024-04-23T08:35:35","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/"},"modified":"2024-04-23T10:35:44","modified_gmt":"2024-04-23T08:35:44","slug":"actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/00-AFT-JUNIO-2023_p.pdf\">Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023<\/a><\/p>\n\n<p>Bases de las combinaciones farmacol\u00f3gicas en oncolog\u00eda<\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/01-EDITORIAL-DEL-DIRECTOR-Farmadrid-29.pdf\"><strong>EDITORIAL DEL DIRECTOR<\/strong>: Farmadrid-29.<\/a><\/p>\n\n<p class=\"has-vivid-red-color has-text-color\"><strong>EDITORIALES INVITADAS<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/02-EDITORIAL-INVITADO-La-SEF-en-el-periodo-1986-1991.pdf\">La SEF en el periodo 1986 &#8211; 1991.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/03-EDITORIAL-INVITADO-Is-there-a-future-for-scientific-animal-research-1.pdf\">Is there a future for scientific animal research?<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/04-EDITORIAL-INVITADO-Unfavorable-outcomes-in-the-search-for-antiviral-drugs-for-COVID-19-treatment.pdf\">Unfavorable outcomes in the search for antiviral drugs for COVID-19 treatment.<\/a><\/p>\n\n<p><a href=\"Oxytocin: therapeutic potential for age-related social disorders.\">Oxytocin: therapeutic potential for age-related social disorders.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/06-EDITORIAL-INVITADO-Bases-de-las-combinaciones-farmacologicas-en-oncologia.pdf\">Bases de las combinaciones farmacol\u00f3gicas en oncolog\u00eda.<\/a><\/p>\n\n<p class=\"has-vivid-red-color has-text-color\"><strong>FARMACOTERAPIA<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/07-FARMACOTERAPIA-Residuos-medicamentosos-de-diclofenaco-y-su-impacto-en-los-buitres-del-genero-Gyps.pdf\">Residuos medicamentosos de diclofenaco y su impacto en los buitres del g\u00e9nero Gyps.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/08-FARMACOTERAPIA-What-quality-of-information-is-found-on-the-Brazilian-internet-about-breast-and-prostate-cancer-treatment.pdf\">What quality of information is found on the Brazilian internet about breast and prostate cancer treatment?.<\/a><\/p>\n\n<p class=\"has-vivid-red-color has-text-color\"><strong>NUEVOS F\u00c1RMACOS<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/09-NUEVOS-FARMACOS-Deucravacitinib-un-nuevo-tratamiento-oral-para-la-psoriasis-en-placas-de-moderada-a-grave.pdf\">Deucravacitinib, un nuevo tratamiento oral para la psoriasis en placas de moderada a grave.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/10-NUEVOS-FARMACOS-Leniolisib-primer-farmaco-para-el-tratamiento-del-sindrome-de-fosfoinositida-3-quinasa-&#x3B4;-activada.pdf\">Leniolisib, primer f\u00e1rmaco para el tratamiento del s\u00edndrome de fosfoinositida 3-quinasa \u03b4 activada.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/11-NUEVOS-FARMACOS-La-FDA-aprueba-el-primer-tratamiento-para-la-ataxia-de-Friedreich.pdf\">La FDA aprueba el primer tratamiento para la ataxia de Friedreich.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/12-NUEVOS-FARMACOS-La-ivermectina-es-ineficaz-para-el-tratamiento-del-COVID-19.pdf\">La ivermectina es ineficaz para el tratamiento del COVID-19.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/13-NUEVOS-FARMACOS-La-FDA-aprueba-el-primer-medicamento-de-administracion-intranasal-para-el-tratamiento-de-la-migrana.pdf\">La FDA aprueba el primer medicamento de administraci\u00f3n intranasal para el tratamiento de la migra\u00f1a.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/14-NUEVOS-FARMACOS-Daprodustat-para-el-tratamiento-de-la-anemia-en-pacientes-con-enfermedad-renal-cronica.pdf\">Daprodustat para el tratamiento de la anemia en pacientes con enfermedad renal cr\u00f3nica.<\/a><\/p>\n\n<p class=\"has-vivid-red-color has-text-color\"><strong>DOCENCIA EN FARMACOLOG\u00cdA<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/15-DOCENCIA-EN-FARMACOLOGIA-Una-experiencia-sobre-la-utilizacion-de-una-plantilla-basada-en-el-metodo-Canvas.pdf\">Una experiencia sobre la utilizaci\u00f3n de una plantilla basada en el m\u00e9todo Canvas para el aprendizaje semipresencial en un m\u00e1ster de desarrollo de medicamentos.<\/a><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/16-DOCENCIA-EN-FARMACOLOGIA-Innovacion-docente-en-farmacologia-relato-de-nuestra-experiencia-en-el-aprendizaje-basado-en-artefactos-ABA.pdf\">Innovaci\u00f3n docente en farmacolog\u00eda: relato de nuestra experiencia en el aprendizaje basado en artefactos (ABA).<\/a><\/p>\n\n<p class=\"has-vivid-red-color has-text-color\"><strong>EL F\u00c1RMACO Y LA PALABRA<\/strong><\/p>\n\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/17-EL-FARMACO-Y-LA-PALABRA-Riendose-hacia-la-buena-salud-como-el-humor-puede-mejorar-tu-bienestar.pdf\">Ri\u00e9ndose hacia la buena salud: c\u00f3mo el humor puede mejorar tu bienestar<\/a><\/p>\n","protected":false},"featured_media":5460,"template":"","categoria_revista":[118],"class_list":["post-6882","revista","type-revista","status-publish","has-post-thumbnail","hentry","categoria_revista-2023-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 Bases de las combinaciones farmacol\u00f3gicas en oncolog\u00eda EDITORIAL DEL DIRECTOR: Farmadrid-29. EDITORIALES INVITADAS La SEF en el periodo 1986 &#8211; 1991. Is there a future for scientific animal research? Unfavorable outcomes in the search for antiviral drugs for COVID-19 treatment. Oxytocin: therapeutic potential for age-related ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-23T08:35:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/portadaAFT2_23.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"341\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/portadaAFT2_23.jpg\",\"datePublished\":\"2024-04-23T08:35:35+00:00\",\"dateModified\":\"2024-04-23T08:35:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/portadaAFT2_23.jpg\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/portadaAFT2_23.jpg\",\"width\":341,\"height\":480},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revistas\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Socesfar\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/socesfar\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 Bases de las combinaciones farmacol\u00f3gicas en oncolog\u00eda EDITORIAL DEL DIRECTOR: Farmadrid-29. EDITORIALES INVITADAS La SEF en el periodo 1986 &#8211; 1991. Is there a future for scientific animal research? Unfavorable outcomes in the search for antiviral drugs for COVID-19 treatment. Oxytocin: therapeutic potential for age-related ... Read more","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","article_modified_time":"2024-04-23T08:35:44+00:00","og_image":[{"width":341,"height":480,"url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/portadaAFT2_23.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/#primaryimage"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/portadaAFT2_23.jpg","datePublished":"2024-04-23T08:35:35+00:00","dateModified":"2024-04-23T08:35:44+00:00","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/#primaryimage","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/portadaAFT2_23.jpg","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/08\/portadaAFT2_23.jpg","width":341,"height":480},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-1-2023-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 2, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":3,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6882\/revisions"}],"predecessor-version":[{"id":6885,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6882\/revisions\/6885"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media\/5460"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=6882"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=6882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}